{"id":45870,"date":"2021-07-14T12:00:11","date_gmt":"2021-07-14T10:00:11","guid":{"rendered":"https:\/\/packaging-journal.de\/?p=45870"},"modified":"2021-07-26T09:16:19","modified_gmt":"2021-07-26T07:16:19","slug":"capacities-for-vaccine-production","status":"publish","type":"post","link":"https:\/\/packaging-journal.de\/en\/kapazitaeten-fuer-die-impfstoffproduktion\/","title":{"rendered":"Vaccine production capacities cannot be expanded indefinitely"},"content":{"rendered":"

Vaccine production against Covid-19 is also a very special task for the manufacturers of filling and packaging systems. Even before authorisation was granted, pharmaceutical companies had already started to expand their production capacities, and there is currently no end in sight. But plants that produce other important medicines must not lose sight of this either.<\/p>\n

Naturally, the southern German Mechanical engineering company Bausch+Str\u00f6bel<\/a>, when one of the company's own plants is shown on the news: Because when it comes to the production of vaccines against Covid-19, the filling and packaging systems from Ilshofen can be seen in action from time to time.<\/p>\n

\u201eWe are naturally pleased and proud that we can make our contribution to the fight against the pandemic - but this also means a great responsibility for us,\u201c says Managing Director Dr Hagen Gehringer. The tasks currently facing all machine manufacturers who produce specialised machines for the pharmaceutical industry are quite general Major challenges<\/strong>.<\/p>

\"\"<\/a><\/div><\/div>\n

In demand: effective lead time<\/strong><\/h2>\n

Pharmaceutical companies prepared for the production of their vaccines at an early stage: They started expanding their production capacities at a time when it was not yet clear whether the developed vaccine would even be authorised. \u201eWithout these preliminary measures, a rapid supply of the vaccine would not currently be possible,\u201c Managing Director Dr Hagen Gehringer is certain. This led very early on to increased Enquiries from specialist machine manufacturers<\/strong>, who are active in this area.<\/p>\n

Demanded: Expansion of vaccine production capacities <\/strong><\/h2>\n

The first enquiries arrived in Ilshofen as early as March 2020: For example, a labelling machine was ordered explicitly for processing a future vaccine, which was delivered a few months later.<\/p>